Alanine Aminotransferase (ALT)

Alanine Aminotransferase (ALT)


Test Overview

An alanine aminotransferase (ALT) test measures the amount of this enzyme in the blood. ALT is found mainly in the liver, but also in smaller amounts in the kidneys, heart, muscles, and pancreas. ALT was formerly called serum glutamic pyruvic transaminase (SGPT).

ALT is measured to see if the liver is damaged or diseased. Low levels of ALT are normally found in the blood. But when the liver is damaged or diseased, it releases ALT into the bloodstream, which makes ALT levels go up. Most increases in ALT levels are caused by liver damage.

The ALT test is often done along with other tests that check for liver damage, including aspartate aminotransferase (AST), alkaline phosphatase, lactate dehydrogenase (LDH), and bilirubin. Both ALT and AST levels are reliable tests for liver damage.

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Latest Hepatitis B News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

Calif. court rejects limits on medical marijuana

January 22, 2010 — LOS ANGELES (Reuters) - The California Supreme Court on Thursday rejected limits on medical marijuana imposed by state lawmakers, finding that people with prescriptions for pot can have and grow all they need for personal use.

US team finds potential path for hepatitis C drugs

January 21, 2010 — WASHINGTON (Reuters) - U.S. scientists have identified a new class of drugs that appear to block the hepatitis C virus from replicating in laboratory experiments, researchers said on Wednesday.

Common chemical may affect liver at low levels

January 13, 2010 — NEW YORK (Reuters Health) - A new study suggests that a synthetic chemical that is ubiquitous in the environment and in people's blood may affect the liver -- though the significance for human health remains unclear.

Select news items provided by Reuters Health